Metformin, a common diabetes medication, has shown significant potential in fighting cancer. Its impact on how cells produce energy, particularly in mitochondria, has been effective against various cancers, including breast, prostate, pancreatic, lung, and liver cancers. This article will explain how Metformin affects cancer cells and its potential as an anti-cancer treatment.

How Metformin Causes Stress in Cancer Cells

Metformin creates a type of stress in cells known as metabolic stress. Healthy cells can handle this stress and may even become stronger, but cancer cells, which are already weak, struggle to survive. This stress is a key reason Metformin could prevent cancer from developing if used early.

How Metformin Works Against Cancer

Here’s a breakdown of how Metformin fights cancer:

  1. Entering Cells: Metformin gets into cells through a transporter called OCT1.
  2. Mitochondrial Effect: Once inside, at high concentrations, Metformin binds to a part of the mitochondria called complex 1, slowing down its function. This reduces the cell’s ability to produce energy (ATP), triggering a chain reaction that activates AMPK, a protein that stops another protein called mTOR, which is needed for cancer cells to grow.
  3. Blocking Fat Production: Metformin also stops acetyl-CoA from entering the TCA cycle, a process that produces fats necessary for cancer cell growth. By blocking this, Metformin helps stop cancer from spreading.
  4. Promoting Cell Death: Metformin increases the ratio of BAX (a protein that promotes cell death) to BCL2 (a protein that prevents cell death). This makes it more likely that cancer cells will die. The increase in BAX triggers a series of events that lead to the death of cancer cells.

Balancing Energy Production

Metformin doesn’t completely shut down energy production in cells because that would be harmful to all cells, not just cancerous ones. Instead, it carefully reduces the energy production in a way that is deadly to cancer cells but tolerable for healthy cells. This selective targeting is what makes Metformin an effective potential treatment for cancer.

Metformin’s Promise in Cancer Treatment

Metformin’s ability to create stress that cancer cells can’t survive, while sparing healthy cells, shows its potential as a powerful anti-cancer agent. By targeting crucial pathways that cancer cells rely on, Metformin could become a key tool in cancer treatment and prevention. Understanding these effects helps us optimize how we use Metformin in fighting cancer, offering hope for better therapies in the future.